C. Alliot

发表

UFT/leucovorin and oxaliplatin alternated with UFT/leucovorin and irinotecan in metastatic colorectal cancer

C. Alliot, 2004, British Journal of Cancer.

Weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients.

C. Alliot, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Twelve‐year mortality results of a randomized trial of 2 versus 5 years of adjuvant tamoxifen for postmenopausal early‐stage breast carcinoma patients (SITAM 01)

C. Alliot, 2006 .

In vivo chemosensitivity-adapted preoperative chemotherapy in patients with early-stage breast cancer.

C. Alliot, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Hodgkin's Disease Variant of Richter's Syndrome: Complete Remission of the both Malignancies after 14 Years

C. Alliot, B. Desablens, S. Tabuteau, 2003, Hematology.

Capecitabine and mitomycin C in patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan

C. Alliot, Van Cutsem, F. E, 2006, British Journal of Cancer.

Relevance of EGFR expression in colorectal cancer.

C. Alliot, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly

C. Alliot, M. Barrios, 2004, British Journal of Cancer.

Opportunistic infection with Rhodotorula in cancer patients treated by chemotherapy: two case reports.

C. Alliot, B. Desablens, S. Tabuteau, 2000, Clinical oncology (Royal College of Radiologists (Great Britain)).

Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly

C. Alliot, M. Barrios, Aparicio T Desramé, 2004, British Journal of Cancer.

Undertreatment of breast cancer in elderly women: contribution of a cancer registry.

C. Alliot, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-fluorouracil and infusional 5-fluorouracil alone in advanced pancreatic carcinoma patients.

C. Alliot, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly population

C. Alliot, 2004, Cancer.

Fluoxetine versus placebo in advanced cancer outpatients.

C. Alliot, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Severe anaphylactic reaction to oxaliplatin.

C. Alliot, J. Rapin, D. Messouak, 2001, Clinical oncology (Royal College of Radiologists (Great Britain)).

Multisystem sarcoidosis and carcinoma of the uterine cervix: an unusual association.

C. Alliot, M. Barrios, C. Desplechain, 2001, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Case Report and Review

C. Alliot, P. Rigaud, P. Derolland, 2003 .

Angiosarcoma variant of Kasabach-Merritt syndrome.

B. Tribout, C. Alliot, M. Barrios, 2001, European journal of gastroenterology & hepatology.

Spontaneous Splenic Rupture Associated with CMV Infection: Report of a Case and Review

C. Alliot, M. Besson, C. Beets, 2001, Scandinavian journal of infectious diseases.

Neurosarcoidosis Associated with Hodgkin's Disease

C. Alliot, B. Desablens, S. Tabuteau, 2000 .

Distinct chromosome 3 abnormalities in persistent polyclonal B‐cell lymphocytosis

G. Salles, B. Coiffier, S. Gazzo, 1999, Genes, Chromosomes and Cancer.

Autoimmune cytopenias associated with malignancies and successfully treated with intravenous immune globulins: about two cases.

C. Alliot, B. Desablens, S. Tabuteau, 2000, Therapie.

Parvovirus B19 Infection in an HIV-Infected Patient with Febrile Pancytopenia and Acute Hepatitis

C. Alliot, M. Brunel, M. Barrios, 2001, European Journal of Clinical Microbiology and Infectious Diseases.

Pulmonary Embolism after Intravenous Immunoglobulin

C. Alliot, F. Bedjaoui, M. Besson, 2001, Journal of the Royal Society of Medicine.

Cytomegalovirus-induced thrombocytopenia in an immunocompetent adult effectively treated with intravenous immunoglobulin: A case report and review

C. Alliot, M. Barrios, 2005, Hematology.

Correction of thrombocytopenia with aspirin in the primary antiphospholipid syndrome

C. Alliot, M. Barrios, D. Messouak, 2001, American journal of hematology.

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

C. Tournigand, M. Espié, B. Weber, 2019, The Lancet.

Systemic Sarcoidosis Preceeding Acute Myeloid Leukemia

C. Alliot, F. Franck, M. Barrios, 2000 .

Twelve‐year mortality results of a randomized trial of 2 versus 5 years of adjuvant tamoxifen for postmenopausal early‐stage breast carcinoma patients (SITAM 01)

C. Alliot, 2005, Cancer.

Fludarabine versus cyclophosphamide, vincristine, and prednisone in recurrent low-grade lymphomas.

C. Alliot, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Venous thrombosis associated with pernicious anaemia. A report of two cases and review

C. Alliot, M. Barrios, 2006, Hematology.

Multisystem sarcoidosis and carcinoma of the uterine cervix: An unusual association

C. Alliot, M. Barrios, C. Desplechain, 2001, International Journal of Gynecologic Cancer.

Efficacy of dapsone in an adolescent with chronic autoimmune thrombocytopenia.

C. Alliot, M. Barrios, 2004, Therapie.

Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer?

C. Alliot, 2006, British Journal of Cancer.

Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer

C. Alliot, 2004, British Journal of Cancer.

Hemophagocytic Syndrome Induced by HIV

C. Alliot, M. Barrios, Michel Brunel, 2001, Hematology.

Edrecolomab in the adjuvant treatment of colorectal carcinoma

C. Alliot, 2003, The Lancet.